Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.
about
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeted mitochondrial therapy ...... combined synergy in diabetes.
@en
Targeted mitochondrial therapy ...... combined synergy in diabetes.
@nl
type
label
Targeted mitochondrial therapy ...... combined synergy in diabetes.
@en
Targeted mitochondrial therapy ...... combined synergy in diabetes.
@nl
prefLabel
Targeted mitochondrial therapy ...... combined synergy in diabetes.
@en
Targeted mitochondrial therapy ...... combined synergy in diabetes.
@nl
P2093
P2860
P50
P1433
P1476
Targeted mitochondrial therapy ...... o combined synergy in diabetes
@en
P2093
Amelia K Fotheringham
Benjamin Harvie
Danielle J Borg
David R Briskey
Domenica A McCarthy
Hannah Shaw
Manuel R Plan
Micheal S Ward
Nicole B Flemming
Peter H Tang
P2860
P2888
P356
10.1038/S41598-017-15589-X
P407
P577
2017-11-09T00:00:00Z